Ampio Pharmaceuticals, Inc.
AMPE
$0.0217
$0.0196933.33%
OTC PK
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Net Income | 7.48% | 80.83% | 33.77% | 29.42% | 64.33% |
Total Depreciation and Amortization | -100.00% | -100.00% | -129.30% | -22.90% | -30.42% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 118.10% | -95.28% | 104.31% | 53.82% | 62.43% |
Change in Net Operating Assets | 85.69% | 177.68% | -79.24% | 68.33% | -172.69% |
Cash from Operations | 46.23% | 90.66% | 42.85% | 53.46% | -15.93% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | 100.00% |
Cash from Financing | -- | -- | -- | -- | -100.00% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 46.23% | 90.66% | 42.85% | 54.48% | -125.60% |